Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2009: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2008: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2007: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Research Abstract |
We investigated the mechanism for the reduced effectiveness of morphine in neuropathic pain stage in this project. With the mechanism investigated, we tried to develop the gene therapy for neuropathic pain. In addition, we also developed the new analgesic amidino-TAPA, which is extremely effective against neuropathic pain.
|